Huron Consulting Group Inc. (HURN) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2026. Huron Consulting Group Inc. is a global professional services firm operating in three segments: Healthcare, Education, and Commercial. The company delivers services through two principal capabilities: Consulting and Managed Services and Digital.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenues | $451.8 million | $404.1 million |
| Revenues Before Reimbursable Expenses (RBR) | $443.7 million | $395.7 million |
| Operating Income | $36.6 million | $32.7 million |
| Net Income | $23.2 million | $24.5 million |
| Diluted EPS | $1.34 | $1.33 |
| Adjusted EBITDA | $50.6 million | $41.5 million |
| Adjusted EBITDA Margin (vs RBR) | 11.4% | 10.5% |
| Cash and Cash Equivalents | $26.5 million | $23.4 million |
| Total Debt Outstanding | $856.0 million | $511.0 million |
| Unused Revolver Capacity | $228.6 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: RBR increased 12.1% year-over-year, driven by a 21.3% increase in Consulting and Managed Services. Organic RBR growth was 7.3%, with $19.3 million attributed to acquisitions completed since December 31, 2024.
- Profitability: While Net Income decreased 5.3% to $23.2 million, Adjusted EBITDA increased 21.9% to $50.6 million. The decline in GAAP Net Income was primarily due to a shift from an income tax benefit in Q1 2025 to an expense in Q1 2026, and a $3.8 million loss from the remeasurement of contingent consideration liabilities.
- Debt Levels: Total borrowings increased significantly to $856.0 million (from $511.0 million) to fund operations, including annual performance bonuses, and share repurchases. The Consolidated Leverage Ratio increased to 3.14x (from 1.93x) but remains within the 3.75x covenant limit.
- Share Repurchases: The company repurchased 1,114,806 shares for $155.5 million in Q1 2026, compared to 508,611 shares for $72.9 million in Q1 2025.
- Segment Performance:
- Healthcare: RBR up 13.5% to $225.2 million; Operating Income up 13.6% to $64.0 million.
- Education: RBR up 3.8% to $127.5 million; Operating Income up 19.6% to $27.6 million.
- Commercial: RBR up 22.3% to $91.0 million; Operating Income up 31.9% to $14.9 million.
Guidance, Outlook, and Risks
- Outlook: Management emphasizes a strategy of accelerating growth in Healthcare and Education, expanding Commercial presence, and growing Digital capabilities. The company targets margin expansion and strong annual adjusted diluted EPS growth.
- Capital Allocation: The company maintains a $900 million share repurchase authorization, with $144.6 million remaining available as of March 31, 2026. Capital is also deployed for strategic acquisitions.
- Risks and Contingencies:
- Debt Covenants: The company is subject to a maximum Consolidated Leverage Ratio of 3.75x (4.25x for Qualified Acquisitions) and a minimum Interest Coverage Ratio of 3.00x. As of March 31, 2026, the company was in compliance (3.14x and 7.57x, respectively).
- Contingent Consideration: A $3.8 million loss was recognized in Q1 2026 due to the remeasurement of contingent consideration liabilities related to business acquisitions. The total estimated fair value of these liabilities is $26.9 million.
- Market Risks: Exposure to interest rate fluctuations on variable-rate debt (hedged via swaps) and foreign currency exchange rates (hedged via forward contracts for INR and CAD).
Investor Verification Checklist
- Debt Utilization: Verify the sustainability of the increased leverage ratio (3.14x) and the impact of higher interest expense ($8.9 million in Q1 2026 vs. $5.6 million in Q1 2025) on future cash flows.
- Acquisition Integration: Assess the performance of recent acquisitions (Treliant, Eclipse Insights, WP&C, AXIOM) which contributed $19.3 million to RBR growth.
- Contingent Consideration: Monitor the $26.9 million liability for contingent consideration, as future remeasurements could impact earnings volatility.
- Share Repurchase Impact: Evaluate the effect of aggressive buybacks ($155.5 million in Q1) on liquidity and the remaining $144.6 million authorization.
- Utilization Rates: Review the slight decline in Digital capability utilization (74.8% vs. 78.2% prior year) versus the increase in Consulting utilization (74.6% vs. 74.1%).